Gene · 3127
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterisation of the Novel HLA-DRB5*01:02:05 Allele by Next-Generation Sequencing. | HLA | 2025 | 40071353 | PubTator, text mining | PubMed |
| Interaction of genetic variants and methylation in transcript-level expression regulation in Alzheimer's disease by multi-omics data analysis. | BMC Genomics | 2025 | 39979805 | PubTator, text mining | PubMed |
| Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulva. | Int J Gynecol Cancer | 2025 | 39971436 | PubTator, text mining | PubMed |
| Genome-Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify Susceptibility Loci for Cervical Cancer. | J Med Virol | 2025 | 39891432 | PubTator, text mining | PubMed |
| RNAseq of peripheral blood mononucleated cells exposed to platelet-rich fibrin and enamel matrix derivatives. | Sci Rep | 2025 | 39881164 | PubTator, text mining | PubMed |
| Single cell transcriptomics in blood of patients with chronic obstructive pulmonary disease. | BMC Pulm Med | 2025 | 39810158 | PubTator, text mining | PubMed |
| Identification of Drug-Targetable Genes for Eczema and Dermatitis Using Integrated Genomic and Proteomic Approaches. | Dermatitis | 2025 | 39786806 | PubTator, text mining | PubMed |
| Sarcopenia and immune-mediated inflammatory diseases: Evaluating causality and exploring therapeutic targets for sarcopenia through Mendelian randomization. | Int Immunopharmacol | 2025 | 39591827 | PubTator, text mining | PubMed |
| Low CD3 level is a risk factor for amyotrophic lateral sclerosis: a Mendelian randomization study. | Amyotroph Lateral Scler Frontotemporal Degener | 2025 | 39316061 | PubTator, text mining | PubMed |
| HLA-DRB5 Overexpression Promotes Platelet Reduction in Immune Thrombocytopenia Mice Model by Facilitating MHC-II-Mediated Antigen Presentation. | Acta Haematol | 2025 | 38744253 | PubTator, text mining | PubMed |
| Unveiling Ventilator-Associated Pneumonia: S100A8 as a Promising Biomarker Through Integrated RNA-Seq Analysis. | J Multidiscip Healthc | 2024 | 39759083 | PubTator, text mining | PubMed |
| Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer. | Microbiome | 2024 | 39731152 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals That C5AR1 in Follicle Monocyte Cells Could Predict the Development of POI. | J Inflamm Res | 2024 | 39717665 | PubTator, text mining | PubMed |
| Characterisation of the Novel HLA-DRB5*02:02:05 Allele by Sequencing-Based Typing. | HLA | 2024 | 39501671 | PubTator, text mining | PubMed |
| Deciphering cell-specific genetic insights: Unraveling the immunogenetic landscape of systemic lupus erythematosus. | Mol Immunol | 2024 | 39476438 | PubTator, text mining | PubMed |
| GEEES: inferring cell-specific gene-enhancer interactions from multi-modal single-cell data. | Bioinformatics | 2024 | 39468737 | PubTator, text mining | PubMed |
| Genome-wide identification of cell type-specific susceptibility genes for Juvenile dermatomyositis through the analysis of N6-methyladenosine-associated SNPs. | Autoimmunity | 2024 | 39447013 | PubTator, text mining | PubMed |
| Analysis of mRNA expression profile in the treatment of diabetic foot ulcer healing by tibial cortex transverse distraction. | Sci Rep | 2024 | 39438549 | PubTator, text mining | PubMed |
| Discovery of potential recombinant alleles HLA-DRB3*02:171 and HLA-DRB5*01:140. | HLA | 2024 | 39291436 | PubTator, text mining | PubMed |
| Exploring the transcriptomic landscape of moyamoya disease and systemic lupus erythematosus: insights into crosstalk genes and immune relationships. | Front Immunol | 2024 | 39290707 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3127/papers?page=5